Add to Favourites
To login click here
Fujitsu, Takeda Pharmaceutical Company Limited, and the National Cancer Center Japan have conducted a joint research project to analyze patient journeys of ovarian cancer patients based on electronic medical record data. The collaboration successfully visualized a wide range of treatment patterns, which are expected to assist physicians and patients in jointly selecting optimal treatment. The study was conducted based on a joint research agreement with the aim of identifying clinical challenges that will contribute to improving the quality and therapeutic efficacy of personalized ovarian cancer treatment.